JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB327056

Anti-ILT-4/CD85d antibody [EPR29046-643]

Anti-ILT-4/CD85d antibody [EPR29046-643]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal ILT-4 antibody. Suitable for IHC-P, Flow Cyt, WB and reacts with Transfected cell line - Human, Human samples.

別名を表示する

CD85d, ILT4, LIR2, MIR10, LILRB2, Leukocyte immunoglobulin-like receptor subfamily B member 2, LIR-2, Leukocyte immunoglobulin-like receptor 2, CD85 antigen-like family member D, Immunoglobulin-like transcript 4, Monocyte/macrophage immunoglobulin-like receptor 10, ILT-4, MIR-10

9 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)

Immunohistochemical analysis of paraffin-embedded Human spleen tissue labeling ILT-4 with ab327056 at 1/100 (5.02 μg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Positive staining on human spleen.

The primary antibody was incubated for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument

Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)

Immunohistochemical analysis of paraffin-embedded Human colon cancer tissue labeling ILT-4 with ab327056 at 1/100 (5.02 μg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Positive staining on immune cells of human colon cancer.

The primary antibody was incubated for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument

Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)

Immunohistochemical analysis of paraffin-embedded Human non-Hodgkin's lymphoma tissue labeling ILT-4 with ab327056 at 1/100 (5.02 μg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Positive staining on human non-Hodgkin's lymphoma.

The primary antibody was incubated for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument

Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Flow Cytometry - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)
  • Flow Cyt

Lab

Flow Cytometry - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)

Flow cytometric analysis of Human PBMC (human peripheral blood mononuclear cell) cells labelling ILT-4 with ab327056 at 1/500 dilution (0.1ug) / Right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).

Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.

Gated on viable cells. Cells were co-stained with CD3 conjugated to Alexa Fluor®647.

Flow Cytometry - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)
  • Flow Cyt

Lab

Flow Cytometry - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)

Flow cytometric analysis of Human PBMC (human peripheral blood mononuclear cell) cells labelling ILT-4 with ab327056 at 1/500 dilution (0.1ug) / Right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).

Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.

Gated on viable cells. Cells were co-stained with CD14 conjugated to Brilliant Violet 421.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)

Immunohistochemical analysis of paraffin-embedded (A) : HEK-293T (human embryonic kidney epithelial cell) cells transfected with a human LILRB2 expression vector containing a his tag. (B) : HEK-293T cells transfected with a human LILRB1 expression vector containing a his tag. (C) : HEK-293T cells transfected with a human LILRA1 expression vector containing a his tag. (D) : HEK-293T cells transfected with a human LILRA3 expression vector containing a his tag. (E) : HEK-293T cells transfected with a human LILRA2 expression vector containing a his tag. (F) : HEK-293T cells transfected with a human LILRA6 expression vector containing a his tag. (G) : HEK-293T cells transfected with a human LILRB3 expression vector containing a his tag. (H) : HEK-293T cells transfected with a human LILRB5 expression vector containing a his tag. (I) : HEK-293T cells transfected with empty vector containing a his tag. tissue labeling ILT-4 with ab327056 at 1/2000 (0.251 μg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Positive staining on (A) HEK-293T cells transfected with a human LILRB2 expression vector containing a his tag, no staining on (B) HEK-293T cells transfected with a human LILRB1 expression vector containing a his tag, (C) HEK-293T cells transfected with a human LILRA1 expression vector containing a his tag, (D) HEK-293T cells transfected with a human LILRA3 expression vector containing a his tag, (E) HEK-293T cells transfected with a human LILRA2 expression vector containing a his tag, (F) HEK-293T cells transfected with a human LILRA6 expression vector containing a his tag, (G) HEK-293T cells transfected with a human LILRB3 expression vector containing a his tag, (H) HEK-293T cells transfected with a human LILRB5 expression vector containing a his tag, and (I) HEK-293T cells transfected with empty vector containing a his tag.

The primary antibody was incubated for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument

Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)

Immunohistochemical analysis of paraffin-embedded Human skeletal muscle tissue labeling ILT-4 with ab327056 at 1/100 (5.02 μg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Low expression tissue : positive staining on immune cells of human skeletal muscle.

The primary antibody was incubated for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument

Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Western blot - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)
  • WB

Lab

Western blot - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Low expression : 293T, Hela.

To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).

All lanes:

Western blot - Anti-ILT-4/CD85d antibody [EPR29046-643] (ab327056) at 1/1000 dilution

Lane 1:

U-937 (human histiocytic lymphoma monocyte) whole cell lysate at 80 µg

Lane 2:

293T (human embryonic kidney epithelial cell) whole cell lysate at 80 µg

Lane 3:

HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 80 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 100 kDa,36 kDa

false

Exposure time: 180s

Western blot - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)
  • WB

Lab

Western blot - Anti-ILT-4/CD85d antibody [EPR29046-643] (AB327056)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Low expression : skeletal muscle.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).

All lanes:

Western blot - Anti-ILT-4/CD85d antibody [EPR29046-643] (ab327056) at 1/1000 dilution

Lane 1:

Human spleen tissue lysate at 80 µg

Lane 2:

Human colon cancer tissue lysate at 80 µg

Lane 3:

Human skeletal muscle tissue lysate at 80 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Observed band size: 75-100 kDa,36 kDa

false

Exposure time: 70s

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR29046-643

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB, Flow Cyt, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/500", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Transfected cell line - Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Conditional Ambient
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles (PubMed : 11169396, PubMed : 12853576, PubMed : 16455647, PubMed : 20448110, PubMed : 27859042). Involved in the down-regulation of the immune response and the development of tolerance. Recognizes HLA-G in complex with B2M/beta-2 microglobulin and a nonamer self-peptide (peptide-bound HLA-G-B2M) triggering differentiation of type 1 regulatory T cells and myeloid-derived suppressor cells, both of which actively maintain maternal-fetal tolerance (PubMed : 16455647, PubMed : 20448110, PubMed : 27859042). Competes with CD8A for binding to class I MHC antigens. Inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions (PubMed : 11875462, PubMed : 12853576, PubMed : 9548455, PubMed : 9842885).
See full target information ILT-4/CD85d

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com